HTG MOLECULAR DIAGNOSTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0025 USD | +66.67% |
|
0.00% | +92.31% |
| 2023 | Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc. | CI |
| 2023 | Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc. | CI |
Chart calendar HTG Molecular Diagnostics, Inc.
a470234eacb8ee65.71irzMUjR4s8FoVs2hqqe0khaSDugLyYURuDVMPDRNs.3wvP-58UBOhWJNAUnW7-LSVPJWW09ezCaWP3EIH3dbyALuSf8GI1_1ZCzA~39055b67dd81ebbe624db87811558067
Upcoming events on HTG Molecular Diagnostics, Inc.
Past events on HTG Molecular Diagnostics, Inc.
| 2023-06-04 | BIO International Convention |
| 2023-05-10 17:51 | Q1 2023 Earnings Release |
| 2023-04-19 09:00 | American Association for Cancer Research Meeting - Abstract Number : 6375 |
| 2023-04-18 09:00 | American Association for Cancer Research Meeting - Abstract Number : 4501 |
| 2023-04-17 09:00 | American Association for Cancer Research Meeting - Abstract Number : 2107 |
| 2023-04-16 13:30 | American Association for Cancer Research Meeting - Abstract Number : 619 |
| 2022-12-13 11:00 | Investor Meeting - Key Opinion Leader |
| 2022-11-10 16:05 | Q3 2022 Earnings Release |
| 2022-09-28 09:50 | Cantor Oncology, Hematology & HemeOnc Conference |
| 2022-08-11 16:30 | Interim 2022 Earnings Call |
| 2022-08-11 16:05 | Interim 2022 Earnings Release |
| 2022-06-16 12:05 | Markets and Markets Biomarker and Companion Diagnostics Conference |
| 2022-06-05 | American Society of Clinical Oncology Meeting - Abstract Number : 583 |
| 2022-06-05 | American Society of Clinical Oncology Meeting - Abstract Number : e15063 |
| 2022-06-05 | American Society of Clinical Oncology Meeting - Abstract Number : 7576 |
| 2022-06-05 | American Society of Clinical Oncology Meeting - Abstract Number : 11549 |
| 2022-05-24 07:00 | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-05-12 16:30 | Q1 2022 Earnings Call |
| 2022-05-12 16:01 | Q1 2022 Earnings Release |
| 2022-03-29 16:30 | FY 2021 Earnings Call |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 21,5 21,5 0.02% | 19,2 19,2 0.01% | 8,55 8,43 1.37% | 8,91 8,92 -0.09% | 6,37 6,36 0.07% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -16,2 -19,4 16.61% | -19,0 -19,2 1.09% | -19,6 -20,8 5.93% | -17,8 -17,4 -2.24% | -20,8 -19,9 -4.89% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,5 -18,7 12.16% | -19,3 -19,8 2.58% | -20,9 -22,2 6.19% | -17,1 -16,6 -3.01% | -21,6 -20,7 -4.39% |
|
Net income Million USD | Released Forecast Spread | -16,5 -18,7 12.15% | -19,3 -19,8 2.73% | -20,9 -22,2 6.15% | -17,1 -16,6 -3.16% | -21,6 -20,7 -4.41% |
|
EPS USD | Released Forecast Spread | -108 -122 11.76% | -91,8 -94,8 3.16% | -54,1 -40,3 -34.23% | -29,6 -28,4 -4.37% | -24,3 -20,3 -19.49% |
| Announcement Date | 07/03/19 | 25/03/20 | 25/03/21 | 29/03/22 | 30/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,44 1,40 2.51% | 2,07 2,13 -2.59% | 2,52 2,73 -7.79% | 2,88 2,90 -0.79% | 1,18 2,15 -44.91% | 1,49 2,35 -36.53% | 1,25 2,83 -55.72% | 2,44 2,44 0.18% | 1,03 1,60 -35.47% |
|
EBIT Million USD | Released Forecast Spread | -4,58 -5,13 10.61% | -4,08 -4,63 11.92% | -4,23 -4,37 3.12% | -4,93 -4,54 -8.7% | -6,25 -5,77 -8.35% | -5,68 -5,81 2.22% | -4,35 -5,80 25.03% | -4,55 -3,58 -27.11% | -5,01 -4,09 -22.56% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,85 -5,55 12.69% | -2,60 -4,77 45.48% | -4,49 -4,50 0.25% | -5,19 -4,67 -11.16% | -6,50 -6,02 -7.89% | -5,88 -5,96 1.22% | -4,51 -5,95 24.12% | -4,69 -3,78 -24.04% | -5,05 -4,29 -17.78% |
|
Net income Million USD | Released Forecast Spread | -4,85 -5,55 12.64% | -2,61 -4,77 45.14% | -4,49 -4,50 0.21% | -5,19 -4,67 -11.2% | -6,50 -6,02 -7.9% | -5,89 -5,96 1.14% | -4,52 -5,95 24.1% | -4,69 -3,78 -24.14% | -5,05 -4,29 -17.83% |
|
EPS USD | Released Forecast Spread | -9,60 -11,8 18.78% | -4,68 -9,04 48.23% | -7,20 -7,72 6.74% | -8,28 -7,08 -16.95% | -9,72 -8,58 -13.29% | -6,48 -7,80 16.92% | -4,92 -6,42 23.36% | -3,16 -2,41 -31.12% | -2,28 -1,94 -17.53% |
| Announcement Date | 13/05/21 | 12/08/21 | 10/11/21 | 29/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 30/03/23 | 10/05/23 |
More events
Past sector events for HTG Molecular Diagnostics, Inc.
| 2024-04-25 02:00 | BIOTAGE AB: Q1 2024 Earnings Release |
| 2024-04-24 | CONTEC MEDICAL SYSTEMS CO.,LTD: Q4 2023 Earnings Release |
| 2024-04-24 | REVENIO GROUP OYJ: Q1 2024 Earnings Release |
| 2024-04-21 | SHANGHAI MICROPORT EP MEDTECH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-18 | SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-18 01:00 | SARTORIUS AG: Q1 2024 Earnings Release |
| 2024-04-09 | SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.: Q4 2023 Earnings Release |
| 2024-03-29 | SHANGHAI MICROPORT EP MEDTECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-02-15 08:00 | BIOTAGE AB: Q4 2023 Earnings Release |
| 2024-02-15 02:00 | REVENIO GROUP OYJ: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HTGMQ Stock
- Calendar HTG Molecular Diagnostics, Inc.
